Yarlagadda S. Babu
2010
In 2010, Yarlagadda S. Babu earned a total compensation of $621.2K as Vice President, Drug Discovery at BioCryst Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $68,161 |
|---|---|
| Option Awards | $225,272 |
| Salary | $315,560 |
| Other | $12,250 |
| Total | $621,243 |
Babu received $315.6K in salary, accounting for 51% of the total pay in 2010.
Babu also received $68.2K in non-equity incentive plan, $225.3K in option awards and $12.3K in other compensation.
Rankings
In 2010, Yarlagadda S. Babu's compensation ranked 6,984th out of 10,439 executives tracked by ExecPay. In other words, Babu earned more than 33.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,984 out of 10,439 | 33rd |
Division Manufacturing | 2,547 out of 3,838 | 34th |
Major group Chemicals And Allied Products | 596 out of 921 | 35th |
Industry group Drugs | 395 out of 680 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 74 out of 142 | 48th |
Source: SEC filing on April 15, 2013.
Babu's colleagues
We found five more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2010.
2010
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2010
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2010
Stuart Grant
BioCryst Pharmaceuticals
Chief Financial Officer
2010
Peter McCullough
BioCryst Pharmaceuticals
Vice President, Operations
2010
David McCullough
BioCryst Pharmaceuticals